Advanced glycation end products induce tubular epithelial-myofibroblast transition through the RAGE-ERK1/2 MAP kinase signaling pathway.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  American Journal of Pathology

• Publication date

  2004-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0002-9440(10)63225-7PMID 15039226PMCID PMC1615341
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Advanced glycation end products activate Smad signaling via TGF‐β‐dependent and ‐independent mechanisms: implications for diabetic renal and vascular disease

  2004cited by this paper
• Advanced glycation end products activate Smad signaling via TGF-beta-dependent and independent mechanisms: implications for diabetic renal and vascular disease.

  2004cited by this paper
• Tubular epithelial-myofibroblast transdifferentiation mechanisms in proximal tubule cells

  2003cited by this paper
• Smad7 inhibits fibrotic effect of TGF-Beta on renal tubular epithelial cells by blocking Smad2 activation.

  2002cited by this paper
• Blockage of tubular epithelial to myofibroblast transition by hepatocyte growth factor prevents renal interstitial fibrosis.

  2002influential reference
• Activation of tubular epithelial cells in diabetic nephropathy.

  2002cited by this paper
• TGF-β signaling in renal disease

  2002cited by this paper
• Receptor for Advanced Glycation End Products (RAGE) Signaling Induces CREB-dependent Chromogranin Expression during Neuronal Differentiation*

  2002cited by this paper
• Role of basic fibroblast growth factor-2 in epithelial-mesenchymal transformation.

  2002cited by this paper
• TGF-beta signaling in renal disease.

  2002cited by this paper
• Diabetic nephropathy: it's in the numbers.

  2002cited by this paper
• Evidence that fibroblasts derive from epithelium during tissue fibrosis.

  2002cited by this paper
• Disruption of tissue-type plasminogen activator gene in mice reduces renal interstitial fibrosis in obstructive nephropathy.

  2002cited by this paper
• Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions.

  2001cited by this paper
• Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice.

  2001cited by this paper
• Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE).

  2001cited by this paper
• Interaction of metabolic and haemodynamic factors in mediating experimental diabetic nephropathy

  2001cited by this paper
• Interleukin-1 induces tubular epithelial-myofibroblast transdifferentiation through a transforming growth factor-beta1-dependent mechanism in vitro.

  2001cited by this paper
• The Raf/MEK/ERK pathway: new concepts of activation

  2001cited by this paper
• Transforming growth factor beta1 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation.

  2001cited by this paper
• Requirement for p38 and p44/p42 mitogen-activated protein kinases in RAGE-mediated nuclear factor-kappaB transcriptional activation and cytokine secretion.

  2001cited by this paper
• Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis.

  2001cited by this paper
• Tubular phenotypic change in progressive tubulointerstitial fibrosis in human glomerulonephritis.

  2001cited by this paper
• Role of myofibroblasts during normal tissue repair and excessive scarring: interest of their assessment in nephropathies.

  2000cited by this paper
• RAGE: a new target for the prevention and treatment of the vascular and inflammatory complications of diabetes.

  2000cited by this paper
• Modulation of transforming growth factor β response and signaling during transdifferentiation of rat hepatic stellate cells to myofibroblasts

  2000cited by this paper
• Pathology of progressive nephropathies.

  2000cited by this paper
• Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro.

  1999cited by this paper
• The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury?

  1999cited by this paper
• Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts

  1998cited by this paper
• Tubular epithelial-myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats.

  1998cited by this paper
• Local macrophage and myofibroblast proliferation in progressive renal injury in the rat remnant kidney.

  1998cited by this paper
• Early role of Fsp1 in epithelial-mesenchymal transformation.

  1997cited by this paper
• Early role of Fsp1 in epithelial-mesenchymal transformation.

  1997cited by this paper
• Activation of the Receptor for Advanced Glycation End Products Triggers a p21 ras -dependent Mitogen-activated Protein Kinase Pathway Regulated by Oxidant Stress*

  1997cited by this paper
• Myofibroblasts and the progression of diabetic nephropathy.

  1997cited by this paper
• Upregulation of Mesangial Growth Factor and Extracellular Matrix Synthesis by Advanced Glycation End Products Via a Receptor-Mediated Mechanism

  1997cited by this paper
• Molecular insights into renal interstitial fibrosis.

  1996cited by this paper
• Interstitial myofibroblasts in IgA glomerulonephritis.

  1995cited by this paper
• Identification and characterization of a fibroblast marker: FSP1

  1995cited by this paper
• A novel, simple, reliable, and sensitive method for multiple immunoenzyme staining: use of microwave oven heating to block antibody crossreactivity and retrieve antigens.

  1995cited by this paper
• PDGF and TGF-beta mediate collagen production by mesangial cells exposed to advanced glycosylation end products.

  1995cited by this paper
• Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging.

  1994cited by this paper
• Advanced glycosylation: chemistry, biology, and implications for diabetes and aging.

  1992cited by this paper
• Advanced glycosylation end products in patients with diabetic nephropathy.

  1991cited by this paper
• Blockade of RAGE ± amphoterin signalling suppresses tumour growth and metastases

  year unknowncited by this paper

• Spinach Extract Reduces Kidney Damage in Diabetic Rats by Impairing the AGEs/RAGE Axis

  2025cites this paper
• E-cadherin as a surrogate marker of epithelial-to-mesenchymal transition for detection of diabetic nephropathy and subclinical atherosclerosis among children and adolescents with type 1 diabete

  2025cites this paper
• Remodeling of the Intracardiac Ganglia During the Development of Cardiovascular Autonomic Dysfunction in Type 2 Diabetes: Molecular Mechanisms and Therapeutics

  2024cites this paper
• Salvianolic acid B in fibrosis treatment: a comprehensive review

  2024cites this paper
• Potential Metabolic Pathways Involved in Osteoporosis and Evaluation of Fracture Risk in Individuals with Diabetes

  2024cites this paper
• Advanced glycation end products and insulin resistance in diabetic nephropathy.

  2024cites this paper
• Circular RNAs and the regulation of gene expression in diabetic nephropathy (Review)

  2024cites this paper
• Ursodeoxycholic acid ameliorates erectile dysfunction and corporal fibrosis in diabetic rats by inhibiting the TGF-β1/Smad2 pathway

  2024cites this paper
• Ferroptosis Mediates the Progression of Hyperuricemic Nephropathy by Activating RAGE Signaling

  2024cites this paper
• Effects of advanced glycation end products via oxidative stress on beta cells: insights from in vitro and in vivo studies and update on emerging therapies.

  2023cites this paper
• Epigenetic modification in diabetic kidney disease

  2023cites this paper
• Chronic hyperglycemia reduces the expression of intercellular adhesion molecules and increases intercellular hyperpermeability in the periodontal epithelium.

  2023cites this paper
• Role of sex hormones in diabetic nephropathy

  2023cites this paper
• RAGE pathway activation and function in chronic kidney disease and COVID-19

  2022cites this paper
• Molecular mechanisms of Biyu decoction as treatment for psoriasis: A network pharmacology and molecular docking study

  2022cites this paper
• Advanced Glycation End Products (AGEs) and Chronic Kidney Disease: Does the Modern Diet AGE the Kidney?

  2022cites this paper
• TGF-beta signal transduction: biology, function and therapy for diseases

  2022cites this paper
• Transforming growth factor-β2-mediated mesenchymal transition in lens epithelial cells is repressed in the absence of RAGE.

  2021cites this paper
• Studies of the Anti-Diabetic Mechanism of Pueraria lobata Based on Metabolomics and Network Pharmacology

  2021cites this paper
• The perplexing role of RAGE in pulmonary fibrosis: causality or casualty?

  2021cites this paper
• Fibrosis of the diabetic heart: clinical significance, molecular mechanisms, and therapeutic opportunities.

  2021cites this paper
• Amelioration of STZ-induced nephropathy in diabetic rats by saffron hydro alcoholic extract

  2021cites this paper
• Inhibition of advanced glycation endproducts formation by lotus seedpod oligomeric procyanidins through RAGE-MAPK signaling and NF-κB activation in high-AGEs-diet mice.

  2021cites this paper
• Structure-activity relationship and hypoglycemic activity of tricyclic matrines with advantage of treating diabetic nephropathy.

  2020cites this paper
• Role of advanced glycation end products and insulin resistance in diabetic nephropathy

  2020cites this paper
• The Role of Dietary Advanced Glycation End Products (AGEs) in Metabolic Dysfunction.

  2020cites this paper
• Antidiabetic and protective effects of Scrophularia striata ethanolic extract on diabetic nephropathy via suppression of RAGE and S100A8 expression in kidney tissues of streptozotocin-induced diabetic rats

  2020cites this paper
• Salvianolic acid B attenuates renal interstitial fibrosis by regulating the HPSE/SDC1 axis

  2020cites this paper
• Diabetic fibrosis.

  2020cites this paper
• The Molecular Mechanism of Transforming Growth Factor-β Signaling for Intestinal Fibrosis: A Mini-Review

  2019cites this paper
• E-cadherin and periostin in early detection and progression of diabetic nephropathy: epithelial-to-mesenchymal transition

  2019cites this paper
• The impact of resveratrol on toxicity and related complications of advanced glycation end products: A systematic review

  2019cites this paper
• Consequences of EMT-Driven Changes in the Immune Microenvironment of Breast Cancer and Therapeutic Response of Cancer Cells

  2019cites this paper
• TGF-β/Smad and Renal Fibrosis.

  2019cites this paper
• Oxalate induces type II epithelial to mesenchymal transition (EMT) in inner medullary collecting duct cells (IMCD) in vitro and stimulate the expression of osteogenic and fibrotic markers in kidney medulla in vivo

  2019cites this paper
• Glyoxalase 1 sustains the metastatic phenotype of prostate cancer cells via EMT control

  2018cites this paper
• The Role of Free Radicals in Autophagy Regulation: Implications for Ageing

  2018cites this paper
• REC8 inhibits EMT by downregulating EGR1 in gastric cancer cells

  2018cites this paper
• RAGE in the pathophysiology of skeletal muscle

  2018cites this paper
• Matrix-bound AGEs enhance TGFβ2-mediated mesenchymal transition of lens epithelial cells via the noncanonical pathway: implications for secondary cataract formation.

  2018cites this paper
• Pleiotropic Actions of Ppar Agonist:A Potential Therapeutic Perspectives in the Treatment of Diabetic Nephropathy

  2018cites this paper
• Epithelial to Mesenchymal Transition (EMT) and Endothelial to Mesenchymal Transition (EndMT): Role and Implications in Kidney Fibrosis.

  2017cites this paper
• Allicin inhibits tubular epithelial-myofibroblast transdifferentiation under high glucose conditions in vitro.

  2017cites this paper
• Renoprotective Effects of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin: A Review in Type 2 Diabetes

  2017cites this paper
• Kidney, heart and brain: three organs targeted by ageing and glycation.

  2017cites this paper
• Developmental neurotoxicity of the hippocampus following in utero exposure to methylmercury: impairment in cell signaling

  2017cites this paper
• Role of HSP60 (HSPD1) in diabetes‐induced renal tubular dysfunction: regulation of intracellular protein aggregation, ATP production, and oxidative stress

  2017cites this paper
• Memory enhancement and protective effects of crocin against D-galactose aging model in the hippocampus of Wistar rats

  2017influential citation
• TGF-β: the master regulator of fibrosis

  2016cites this paper
• Molecular mechanisms of the antiglycative and cardioprotective activities of Psidium guajava leaves in the rat diabetic myocardium

  2016influential citation
• Carboxymethyl lysine induces EMT in podocytes through transcription factor ZEB2: Implications for podocyte depletion and proteinuria in diabetes mellitus.

  2016cites this paper
• Title C-Reactive Protein Promotes Diabetic Kidney Disease in db / dbMice via the CD 32 b-Smad 3-mTOR signaling Pathway

  2016cites this paper
• Advanced glycation end products (AGEs) promote melanogenesis through receptor for AGEs

  2016cites this paper
• Pathogenesis of Macrovascular Complications in Diabetes

  2016cites this paper
• The origin of renal fibroblasts/myofibroblasts and the signals that trigger fibrosis.

  2016cites this paper
• Effects of candesartan cilexetil and amlodipine orotate on receptor for advanced glycation end products expression in the aortic wall of Otsuka Long-Evans Tokushima Fatty (OETFF) type 2 diabetic rats

  2016cites this paper
• C-Reactive Protein Promotes Diabetic Kidney Disease in db/db Mice via the CD32b-Smad3-mTOR signaling Pathway

  2016cites this paper
• Effects of candesartan cilexetil and amlodipine orotate on receptor for advanced glycation end products expression in the aortic wall of Otsuka Long-Evans Tokushima Fatty (OETFF) type 2 diabetic rats

  2016influential citation
• Humoral beta-cell autoimmunity, AGER gene polymorphism, and circulating soluble RAGE in pre-clinical and clinical type 1 diabetes

  2016cites this paper
• Advanced glycation end products increase lipids accumulation in macrophages through upregulation of receptor of advanced glycation end products: increasing uptake, esterification and decreasing efflux of cholesterol

  2016cites this paper
• AGE-RAGE interaction in the TGFβ2-mediated epithelial to mesenchymal transition of human lens epithelial cells

  2016cites this paper
• Glyoxalase I drives epithelial-to-mesenchymal transition via argpyrimidine-modified Hsp70, miR-21 and SMAD signalling in human bronchial cells BEAS-2B chronically exposed to crystalline silica Min-U-Sil 5: Transformation into a neoplastic-like phenotype.

  2016cites this paper
• Stimulation of transforming growth factor-beta-1 and contact with type I collagen cooperatively facilitate irreversible transdifferentiation in proximal tubular cells

  2016cites this paper
• Novel Therapies for Diabetic Kidney Disease: Storied Past and Forward Paths

  2015cites this paper
• Full Reviews Potential role of Akt signaling in chronic kidney disease

  2015cites this paper
• Potential role of Akt signaling in chronic kidney disease.

  2015cites this paper
• Pancreatic cancer stromal biology and therapy

  2015cites this paper
• RAGE Mediates the Pro-Migratory Response of Extracellular S100A4 in Human Thyroid Cancer Cells

  2015cites this paper
• HMGB1 Enhances the AGE-Induced Expression of CTGF and TGF-β via RAGE-Dependent Signaling in Renal Tubular Epithelial Cells

  2015cites this paper
• Emphysema requires the receptor for advanced glycation end-products triggering on structural cells.

  2015cites this paper
• Antifibrotic properties of receptor for advanced glycation end products in idiopathic pulmonary fibrosis.

  2015cites this paper
• Extracellular matrix is modulated in advanced glycation end products milieu via a RAGE receptor dependent pathway boosted by transforming growth factor‐β1 在晚期糖基化终末产物环境中细胞外基质通过RAGE受体依赖性途径调节，转化生长因子‐β1可以促进这种调节

  2015cites this paper
• Enhanced Epithelial-to-Mesenchymal Transition Associated with Lysosome Dysfunction in Podocytes: Role of p62/Sequestosome 1 as a Signaling Hub

  2015cites this paper
• Research progress in signalling pathway in diabetic nephropathy

  2015cites this paper
• Advanced Glycation End Products Induce Endothelial-to-Mesenchymal Transition via Downregulating Sirt 1 and Upregulating TGF-β in Human Endothelial Cells

  2015cites this paper
• Glycated Serum Albumin and AGE Receptors.

  2015cites this paper
• Advanced Glycation End Products and Oxidative Stress in Type 2 Diabetes Mellitus

  2015cites this paper
• Novel Inhibitory Effects of Glycyrrhizic Acid on the Accumulation of Advanced Glycation End Product and Its Receptor Expression

  2014cites this paper
• Oxytocin alleviates cisplatin-induced renal damage in rats

  2014cites this paper
• Matrix metalloproteinase 1 and circulating tumor cells in early breast cancer

  2014cites this paper
• Angiotensin-(1-7) abolishes AGE-induced cellular hypertrophy and myofibroblast transformation via inhibition of ERK1/2.

  2014cites this paper
• [Changes in the extracellular matrix due to diabetes and their impact on urinary continence].

  2014cites this paper
• Targeting of Receptors for Advanced Glycation End-Products (RAGE) Diminishes Acute Secondhand Smoke-Induced Inflammation in Mice

  2014cites this paper
• Angiotensin-( 1-7 ) Abolishes AGE-Induced Cellular Hypertrophy and Myofibroblast Transformation via Inhibition of ERK 1 / 2

  2014cites this paper
• A role for angiotensin-(1-7) to attenuate advanced glycation end product -induced myofibroblast transition in the NRK-52E renal proximal tubule cell line

  2014influential citation
• Molecular mechanisms of AGE/RAGE-mediated fibrosis in the diabetic heart.

  2014cites this paper
• Tubulointerstitial Injury: Signaling Pathways, Inflammation, Fibrogenesis

  2014cites this paper
• [Advanced glycation end products: A risk factor for human health].

  2014cites this paper
• Alterações da matriz extracelular causadas pelo diabetes: o impacto sobre a continência urinária

  2014cites this paper
• Reprint of "accumulation of modified proteins and aggregate formation in aging".

  2014cites this paper
• Where are we in diabetic nephropathy: microRNAs and biomarkers?

  2014cites this paper
• Accumulation of modified proteins and aggregate formation in aging.

  2014cites this paper
• Cell culture condition-dependent impact of AGE-rich food extracts on kinase activation and cell survival on human fibroblasts

  2014cites this paper
• Akt2 Mediates TGF-β1-Induced Epithelial to Mesenchymal Transition by Deactivating GSK3β/Snail Signaling Pathway in Renal Tubular Epithelial Cells

  2014cites this paper
• Quercetin protects against the Aβ(25-35)-induced amnesic injury: involvement of inactivation of rage-mediated pathway and conservation of the NVU.

  2013cites this paper
• S100B Expression Modulates Diabetic Myocardium following Myocardial Infarction and Development of Diabetes

  2013cites this paper
• Targeted Disruption of Orchestration between Stroma and Tumor Cells in Pancreatic Cancer: Molecular Basis and Therapeutic Implications

  2013cites this paper
• RAGE regulation and signaling in inflammation and beyond

  2013cites this paper
• Role of the TGF-β/BMP-7/Smad pathways in renal diseases.

  2013cites this paper
• Novel non-canonical TGF-β signaling networks: emerging roles in airway smooth muscle phenotype and function.

  2013cites this paper